WHO
The silent killer: why chronic respiratory disease deserves global attention
Multisectoral Action
25 Nov 2024
News
Clinical trials are neglecting the interplay between COVID-19 and chronic diseases, analysis shows
The George Institute for Global Health | 30 Sep 2020
The George Institute for Global Health
People living with non-communicable diseases (NCDs) such as heart disease and diabetes are more vulnerable to becoming severely ill or dying from COVID-19, and yet of all the interventional clinical trials registered globally that relate to COVID-19, less than 4% focus on this high-risk group, an analysis by The George Institute has shown.
Read more here.
